HCV test and trace | GileadPro

This website is developed and funded by Gilead Sciences Ltd and intended for healthcare professionals in the United Kingdom. Adverse Events Reporting

The content of this webpage is promotional, and may contain information about Gilead's medicinal products. It is intended only for healthcare professionals and other relevant decision makers in the UK.

hcv-super-clinic-banner

HCV test and trace

Recorded: March 2nd 2023
Duration: 31:13

Stuart McPherson, Consultant Hepatologist, Freeman Hospital, Newcastle presented the rationale, process and results from the first nine months of a test & trace pilot in HCV. Test & trace had been used successfully in the context of human immunodeficiency virus (HIV), but this was new territory for HCV. The North East and Cumbria region has the highest rates
of HCV reinfection in the country, so a key objective of the scheme was to reach individuals who were potentially fuelling this concerning trend. With careful consenting and incentives, individuals with diagnosed HCV were asked to ‘bring a friend’ for testing. While the number of individuals actually bringing others to be tested was lower than hoped, those who did brought just over three people each and the pilot identified a significant number of infected individuals. However, challenges remain
in converting infected patients into treated patients.

About the speaker

Lisa Ellis
Dr Stuart McPherson

Dr Stuart McPherson is a Consultant Liver Specialist who joined the Newcastle Hospitals in 2010. He is currently Head of Department for Liver Medicine.

Stuart completed undergraduate medical training at St Andrews and Manchester Universities and subsequently undertook specialist training in Glasgow and Newcastle. In addition, he spent two years in Brisbane, Australia researching hepatitis C and fatty liver disease.

Stuart manages patients with liver disease and runs specialist clinics for viral hepatitis, fatty liver disease and cirrhosis. In 2017 he led the team to win the prestigious Royal College of Physicians Quality Improvement Award for developing a decompensated cirrhosis care bundle that was shown to improve care of patients with cirrhosis and is now used in most centres in the UK.

Prescribing information

HCV Medicines Prescribing Information
liver-connect

LIVER Connect Meetings

As requested by attendees, a selection of webinars from
2022 onwards are now available to watch on demand
You can also register here to attend the live webinars

Sign up now
Stay up to date

Receive email updates from Gilead, including promotional communications.

Register

UKI-UNB-2445 | June 2026